Regarding "Incidence of Occult Uterine Malignancy Following Vaginal Hysterectomy with Morcellation".
William H Parker, Jonathan S Berek, Elizabeth A Pritts...
https://pubmed.ncbi.nlm.nih.gov/28826956/Actively Recruiting
Led by Wael Elbanna Clinic · Updated on 2022-03-04
162
Participants Needed
1
Research Sites
130 weeks
Total Duration
Researchers are evaluating the effects of intramyometrial injections of Terlipressin versus Carbetocin on hemoglobin levels and blood loss in women undergoing open myomectomy without the use of haemostatic tourniquets. This prospective, comparative, double-blinded randomized placebo-controlled trial aims to provide clinical evidence to guide best practices and improve outcomes for women with myoma undergoing this surgery. The study is conducted at multiple centers and includes women with relevant myoma-related symptoms. Participants are randomly assigned to one of three groups receiving intramyometrial Terlipressin, Carbetocin, or a saline injection during their open myomectomy procedure. The study excludes the use of mechanical tourniquets in all groups. The treatments are administered during surgery, and the groups are balanced with a 111 allocation ratio using computer-generated randomization. During the study, women will have their blood loss measured during surgery and hemoglobin levels monitored before and after the operation. Additional assessments include operative time and pain severity using a visual analog scale within 24 hours post-surgery. Blood tests and ultrasound are used for evaluations, and all data are collected confidentially. Safety and outcomes are monitored closely, with participation lasting through the immediate perioperative period up to 24 hours after surgery.
CONDITIONS
The Effect of Intramyometrial Injection of Terlipressin Versus Carbitocin on Hemoglobin and Blood Loss During Open Myomectomy Operations Without Using Haemostatic Tourniquets
W
Wael El Banna
E
Esraa mohammad
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Wael Elbanna Clinic
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Surgery day plus 24 hours post-surgery
Participants undergo open myomectomy surgery and receive an intramyometrial injection of Terlipressin, Carbetocin, or saline during the operation without using haemostatic tourniquets.
1 surgery visit and follow-up assessments within 24 hours
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Have more questions? Get in touch with our team for quick support
William H Parker, Jonathan S Berek, Elizabeth A Pritts...
https://pubmed.ncbi.nlm.nih.gov/28826956/Wael Elbanna Clinic
Lead Sponsor